Vol 69, No 9 (2011)
Reviews
Published online: 2011-09-19
Is there a place for treatment with type 5 phosphodiesterase inhibitors in heart failure patients?
DOI: 10.33963/v.kp.79184
Kardiol Pol 2011;69(9):952-957.
Abstract
Not available